Trial Profile
A real world cohort study evaluating risk of incident liver cancer associated with sofosbuvir-containing regimens in hepatitis C virus patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2017
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 01 Feb 2017 New trial record